PCN9 ATIME-IN-MOTION STUDY OF ORAL IBANDRONATE VERSUS IV ZOLEDRONIC ACID FOR THE TREATMENT OF METASTATIC BONE DISEASE IN BREAST CANCER PATIENTS IN THE UK
Nov 1, 2004, 00:00
10.1016/S1098-3015(10)65743-9
https://www.valueinhealthjournal.com/article/S1098-3015(10)65743-9/fulltext
Title :
PCN9 ATIME-IN-MOTION STUDY OF ORAL IBANDRONATE VERSUS IV ZOLEDRONIC ACID FOR THE TREATMENT OF METASTATIC BONE DISEASE IN BREAST CANCER PATIENTS IN THE UK
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)65743-9&doi=10.1016/S1098-3015(10)65743-9
First page :
Section Title :
Open access? :
No
Section Order :
108